News & Events - CRF

News

PCR and TCT Announce the Creation of a New Educational Program: Partners in Learning
InterVene, Inc. Wins TCT 2019 Shark Tank Innovation Competition
New Research Aims to Reduce Risk of Contrast-Induced Kidney Injury in High Risk Patients
Study Finds Sustained Health Status Benefit for TAVR over SAVR at One Year
Transcatheter Mitral Valve Replacement Found to Be Cost-Effective in Patients with Heart Failure and Severe Secondary Mitral Regurgitation
New Five-Year Data Shows Similar Outcomes for TAVR and SAVR in Patients with Severe Aortic Stenosis and Intermediate Surgical Risk
Three-Year COAPT Data Demonstrates Continued Safety and Effectiveness in Patients with Heart Failure and Secondary Mitral Regurgitation
New Data Show that Patients with Left Main Disease Treated with PCI or CABG Have Similar Composite Outcomes at Five Years
New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis
New Self-expanding TAVR Prosthesis Does Not Meet Non-Inferiority Compared to SAPIEN 3
TCT 2019 Master Operator Award to Be Presented to Shigeru Saito, MD
Shortened Three-month DAPT Duration After PCI Demonstrates Low Rate of Adverse Events in High-Bleeding Risk Patients
Biodegradable Polymer Everolimus-eluting Stent with Shortened DAPT is Safe and Effective for PCI in Patients with Unprotected Left Main Coronary Artery Disease
Durable Polymer Drug-Eluting Stent Noninferior to a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated with One-Month DAPT
Ticagrelor Without Aspirin Three Months After Successful PCI and DAPT Reduces Major Bleeding Without Increasing the Risk of Adverse Events
TCT 2019 Career Achievement Award to be Presented to Robert O. Bonow, MD, MS
CRF Fellow Publishes Research Letter Examining Pulmonary Embolism Outcomes in JAMA
Announcing the TCT 2019 Late-Breaking Trials and Science
TCT 2019 Agenda Now Available
CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium